Hundreds of IVC (inferior vena cava) filter lawsuits filed against C.R. Bard, Inc. continue to move forward in the multidistrict litigation now underway in the U.S. District Court, District of Arizona. Court records indicate that the proceeding convened its eighth Case Management Conference on February 17th, at which time several issues pertaining to discovery and motion practice were addressed.
There are currently more than 1,400 IVC filter lawsuits pending in the federal litigation. All of the cases were filed on behalf of patients who allegedly suffered serious complications due to Bard’s retrievable blood clot filters, including its Recovery, G2, Denali and Meridian products. According to RXInjuryHelp.com, the devices are implanted in the inferior vena cava in patients who are at risk for pulmonary embolism, and who are not able to use standard blood-thinning medications. However, plaintiffs claim that Bard’s IVC filters are prone to tilt out of position and/or fracture, resulting in perforation of the inferior vena cava, as well as migration of small pieces to the heart or lungs.
According to a Case Management Order issued in the wake of the litigation’s most recent conference, plaintiffs have been given until April 7, 2017 to submit expert witness reports regarding the Meridian and Denali filters, while defendants must submit any rebuttal reports to the Court by June 9, 2017. Plaintiffs’ experts will be deposed between June 9 and July 14, 2017.
The Order further directs defendants to submit any motion seeking summary judgement on the basis of preemption by March 17, 2017.
Finally, the Order notes that the fact discovery period for the multidistrict litigation has ended. The parties have been directed to confer on any remaining discovery disputes. They are to submit a joint report detailing any unresolved issues to the Court on or before March 17, 2017.
The Court will convene its next Status Conference on May 3, 2017 at 3:00 p.m. The parties are to provide the Court with a joint status report by April 28th.
The nationwide law firm of Bernstein Liebhard LLP is providing legal assistances to individuals who suffered serious complications following implantation of a Bard IVC filter. To discuss your available options with a member of our staff, please call (888) 674-0093.